Dr. Kamyar’s clinical and investigative interests include evaluation and management of lung transplantation; alpha 1 antitrypsin deficiency/COPD and advanced stages management; sarcoidosis, lymphangioleiomyomatosis, and Interstitial Lung Disease management; and phenotypic variance in cystic fibrosis.
Dr. Akuthota’s clinical interests include asthma; eosinophilic pulmonary disease, including EGPA (Churg-Strauss syndrome), eosinophilic pneumonias, allergic bronchopulmonary aspergillosis, and hypereosinophilic syndromes; and critical care medicine. His investigative interests range from basic research in eosinophil immunobiology to clinical research in asthma and eosinophilic pulmonary diseases.
Dr. Bazhenov’s investigative interests include the role of sleep in memory and learning, cancer cell population dynamics, neural mechanisms in obstructive sleep apnea, information coding in the olfactory system, and the neural mechanisms of seizures.
Dr. Begovic’s clinical and investigative interests include acute respiratory distress syndrome, medical treatment for drug dependence, staffing in intensive care units, and intensive care unit telemedicine.
Dr. Conrad’s clinical interests include diseases of the airways, asthma, cystic fibrosis, and diffuse bronchiecstasis. His investigative interests include the response of airway epithelium to various stimuli particularly involved with inflammation; a focus specifically on the regulations of protein expression of CFTR and the lipid per oxidating enzyme 15-lipoxygenase using transgenic mouse models of asthma and pseudomanias aeruginosa pneumonia.
Dr. Crotty Alexander’s clinical interests include critical-care medicine, asthma, and chronic inflammatory lung disease. Her investigative interests include asthma, microbial pathogenesis in the lung, innate immunity in the lung, hypoxia inducible factor, and extracellular traps.
Dr. Crouch’s clinical interests include general pulmonary medicine, asthma and critical care medicine. His investigative interests include chronic obstructive pulmonary disease management and outcomes, chronic thromboembolic disease, cardiac arrest and resuscitation medicine and medical education.
Dr. ElMaraachli’s clinical interests include Bronchiectasis, drug-resistant Tuberculosis and nontuberculosis Mycobacterial lung infections. His investigative interests include drug-resistant Tuberculosis and improving Tuberculosis diagnostics through more efficient sample collection.
Phillip Factor, DO, serves as associate chief medical officer (ACMO) of Inpatient Operations. Dr. Factor is responsible for coordinating key hospital-based services, including critical care, hospitalists, palliative care and infectious disease, as well as inpatient flow and capacity. Dr. Factor’s goals include: increasing the engagement of our medical staff, expanding our critical care programs, improving quality and safety throughout our hospitals and reducing the length of hospital stays to increase access to care for our patients.
Dr. Fedullo’s clinical interests include Chronic thromboembolic pulmonary hypertension, Acute venous thromboembolism, and critical-care medicine. His investigative interests include natural history, diagnosis, and therapy, of acute and chronic thromboembolic disease; and critical-care medicine.
Dr. Fernandes’ clinical interests include venous thromboembolism, chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. His investigative Interests include epidemiology of hospital-acquired venous thromboembolism, progression from acute PE to CTEPH and outcomes after pulmonary thromboendarterectomy.
Dr. Fuster’s clinical interests include lung cancer, radiation tumor biopsy and lung injury, and thromboembolic pathophysiology. His investigative interests include mechanisms of tumor neovacularization, roles of tumor glycoscylation in metastasis, role of proteoglycans in tumor lymphaticprogression, radiation tumor biology, and thromboembolism in cancer.
Dr. Ibrahim’s clinical interests include global challenges in treating COPD, diffuse interstitial lung disease, and upper airway dysfunction induced dyspnea. His investigative interests include tissue culture techniques, TGF-BETA effect on te chemicaly injured retina, effect of various growth factors on the regeneration of the pigmented epithelium in the white New Zealand rabbit, and norcardiasis in HIV + Pleural Effusion.
Dr. Kerr’s clinical interests include pulmonary vascular disease, reperfusion lung injury, and ARDS/ALI. Her investigative interests include CTEPH, Reperfusion lung injury following PTE, and ARDS/ALI.
Dr. Kim’s clinical interests include pulmonary hypertension, chronic thromboembolic pulmonary hypertension (CTEPH), and balloon pulmonary angioplasty. His investigative interests include clinical trials in pulmonary hypertension and pre-operative evaluation and treatment outcome in CTEPH.